Vivos Therapeutics Inc (VVOS) Stock Analysis

Vivos Therapeutics Inc (VVOS) is a publicly traded company in the HEALTHCARE sector. It trades at $0.68, carries a market capitalization of $9.73M. This page summarizes the public market data, fundamentals, and frequently asked questions for VVOS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

Market Sentiment

Vivos Therapeutics Inc currently has a Neutral sentiment score of 0.10.

About Vivos Therapeutics Inc

Vivos Therapeutics, Inc. (VVOS) is a pioneering medical technology company based in Highlands Ranch, Colorado, dedicated to revolutionizing the management of sleep-disordered breathing, particularly mild to moderate obstructive sleep apnea (OSA). Through its proprietary, non-invasive therapeutic solutions, Vivos is addressing the underlying causes of these conditions to enhance patient outcomes significantly. With a strong commitment to innovation, the company is positioned to capture a subst...

GNG Research Analysis

GNG Research scores Vivos Therapeutics Inc (VVOS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VVOS.

Frequently Asked Questions

Does VVOS pay dividends?

Vivos Therapeutics Inc (VVOS) does not currently pay a regular dividend.

What is VVOS's market cap?

Vivos Therapeutics Inc (VVOS) has a market capitalization of $9.73M with a current stock price of $0.68.